All News

Orlando, FL-Among men with prostate cancer, declines in mortality and hospitalization have exceeded those in cardiovascular and other competing diseases, and most deaths among prostate cancer patients are now due to non-prostate cancer causes.

Orlando, FL-Just as researchers were beginning to quantify the value of PC-SPES in treating advanced prostate cancer, the product was found to be contaminated, was taken off the market, and the manufacturer went out of business.

Orlando, FL-A new analysis of data from the National Cancer Institute'snationwide Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screeningtrial suggests that annual PSA screening may not be necessary for many men.

Orlando, FL-A study by researchers from Memorial Sloan-Kettering Cancer Center in New York has given added strength to the recommendation that patients who develop unilateral testicular germ cell tumors should be followed carefully over their lifetimes. The interval between development of a first and second tumor can be 20 or more years, according to their retrospective, 50-year review.

Insertion order form

Q Why is there such a great price discrepancy between disability insurancepolicies?

Another cut is possibleunless formula used to determine physician payments is fixedWashington-It's the big money squeeze, and that's what members of Congressare facing as they seek to resolve several crucial health policy issuesimportant to urologists over the summer months with Congressional electionson the horizon.

Birmingham, United Kingdom-Using standard x-rays, a digital camera orscanner, and a basic graphics software package, physicians can reliablydetermine the chemical composition of urinary calculi, thereby aiding treatmentplanning, say German urologists.

San Francisco-Prostate cancer bone metastases appear to react favorablyto treatment with a new bisphosphonate and the tyrosine-kinase inhibitorsPKI-166 and STI-571, according to studies presented at the American Associationfor Cancer Research annual meeting here.

The recent review of a large series of patients with bilateral testiculargerm cell cancer treated at Memorial Sloan-Kettering Cancer Center (seearticle, page 8) is interesting and important to practicing urologists whoencounter this disease for three key reasons. First, this study, involving a very large series of patients with bilateraltestis tumors, corroborates the following facts that are well recognizedabout bilateral testicular cancer:

The depreciation deduction is quite flexible. It is an allowance forthe wear and tear, the natural deterioration, or the technical obsolescenceof the assets and property used in a medical practice. It is nothing morethan spreading out the original cost of those business assets over theirestimated life.

San Francisco-Herbal tea from Northern Greece, green tea, and black teaare all cytotoxic to human bladder cancer cells, according to a study conductedat the Medical College of Virginia in Richmond. The Greek herbal beveragehad significant cytotoxicity even at 5% concentration.

An article in the December 2001 issue of Urology Times discussed howurologists approach the difficult or demanding patient ("How does yourpractice deal with difficult patients?" page 22). I was impressed howmost physicians managed this situation, and it prompted me to think abouttechniques I have used to help control patients without losing them or allowingthem to be disruptive to the staff and other patients.

Orlando, FL-Reports of the prophylactic properties of isoflavones and other natural substances on cancer cell lines are common, but few-if any-have demonstrated properties as potentially strong as those evidenced by a Japanese nutritional supplement containing a novel form of genistein.

Recently discovered protein found to be present in 95% of all localizedcancer cells

In female patients, pubovaginal sling surgery is the gold standard treatment for stress urinary incontinence. Due to its high success rate in women, a similar technique has been adapted for use in men with severe post-prostatectomy incontinence.

Urinary incontinence (UI) is a serious medical health problem that affects more than 20 million Americans. It is classified into 6 categories including urge incontinence, stress incontinence, and mixed incontinence. Recently, the combination of urgency and frequency, with or without urge urinary incontinence, has been described as overactive bladder (OAB).

Urinary incontinence (UI) is a disease that can decrease a person's overall quality of life. It may lead to disability, social seclusion, psychological stress, and economic burden.

IntroductionThe purpose of this supplement is to provide clinicians with a better understanding of the pathophysiology and management of OAB. Each article provides practical information to the physician treating urinary incontinence and OAB symptoms in clinical practice. This information will be useful in making sound therapeutic decisions based on the most current data available on urinary incontenence and OAB.Based on a satellite symposium held just prior to the American Urological Association 2001 Annual Meeting.This supplement is supported by an unrestricted educational grant from Watson Urology, a division of Watson Pharma, Inc.

Urinary incontinence is defined as the involuntary loss of urine. There are a number of distinct types of urinary incontinence, with overactive bladder (OAB) being a prevalent form. Overactive bladder is the result of involuntary contractions of the detrusor muscle that can occur because of physiological and/or pathological changes in the bladder and its nerve supply. Whereas OAB can affect a person at any age, it is a common disorder among the elderly.

Overactive bladder (OAB), the most prevalent form of urinary incontinence, is due to involuntary contractions of the bladder (detrusor) muscle with symptoms of urinary frequency, urgency, and urge incontinence. Overactive bladder is often managed with pharmacologic intervention that focuses on inhibiting detrusor activity and increasing bladder capacity.

Urinary incontinence (UI) is a common condition in persons over 65 years of age. In the United States alone, there is a 30% prevalence rate in the community and greater than 50% prevalence in nursing homes.1 Even though prevalence increases with age, UI is never normal and it remains treatable regardless of age.

Characterized by symptoms of urinary frequency, urgency, and urge urinary incontinence, overactive bladder (OAB) is a condition that results from a deficiency in the bladder's ability to store urine and in the onset of involuntary bladder muscle contractions that promote urgency and possibly urine loss.

Orlando, FL-A study from Washington University, St. Louis, may have torpedoed a long-standing misconception concerning the pain-relieving benefits of kidney cyst decortication, while at the same time, raising a question whose answer could have important clinical implications.

New Products as presented in the May 1, 2002 issue of Urology Times

What was your attraction to using PVP?

What are the benefits of PVP to the urologists?

How well do patients tolerate PVP with local or minimal anesthesia?

How do you determine if a patient is an appropriate candidate for PVP?

Please explain the importance of BPH in urology practice